Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Viral Immunol ; 30(7): 500-507, 2017 09.
Article in English | MEDLINE | ID: mdl-28598267

ABSTRACT

Intravenous immunoglobulin (IVIG) is used to treat or prevent severe viral infection, especially cytomegalovirus (CMV) infections. IVIG was characterized to understand its interaction with CMV-infected cells. IVIG retarded CMV spread and reduced virus yields depending on the neutralizing (NT) antibody titer. Immediate early protein synthesis was reduced by IVIG in 3 to 15 h, and IVIG specifically reduced the ratio of 66/68k protein synthesis among immediate early proteins in an NT antibody-dependent manner between 4 and 8 h after infection, indicating that antigenic modulation of CMV-infected cells by IVIG reduced viral protein synthesis and virus production. The half-life of antibody bound to CMV-infected cells was 3.8 h. NT antibody titers to varicella-zoster virus (VZV) and CMV in IVIG were dose dependently absorbed by cells infected with VZV and CMV, respectively, but the antibody titers to CMV and VZV, respectively, were not affected. NT antibody in 0.3 mL of IVIG (15 mg) was specifically absorbed by 108 CMV-infected cells and 107 VZV-infected cells, suggesting that the NT antibody in IVIG might be inactivated by one-tenth of a similar volume of CMV-infected or VZV-infected cells. Various antiviral activities of IVIG may contribute to control and alleviation of CMV infection.


Subject(s)
Antibodies, Neutralizing/immunology , Cytomegalovirus Infections/immunology , Cytomegalovirus/immunology , Immunoglobulin G/immunology , Antibodies, Viral/immunology , Antigenic Modulation , Antiviral Agents/immunology , Cells, Cultured , Humans , Immediate-Early Proteins/metabolism , Immunoglobulin G/metabolism , Immunoglobulins, Intravenous/immunology , Neutralization Tests , Virus Release/immunology
2.
Clin Case Rep ; 3(6): 461-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26185649

ABSTRACT

Herpes simplex virus 2 caused a genital ulcer, and a secondary herpetic whitlow appeared during acyclovir therapy. The secondary and recurrent whitlow isolates were acyclovir-resistant and temperature-sensitive in contrast to a genital isolate. We identified the ribonucleotide reductase mutation responsible for temperature-sensitivity by deep-sequencing analysis.

3.
J Infect Chemother ; 21(6): 427-33, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25824903

ABSTRACT

Intravenous immunoglobulin (IVIG) is used to treat severe viral infection, especially varicella-zoster virus (VZV) and cytomegalovirus (CMV) infections. The neutralization antibody titers of eleven IVIG preparations from four companies were examined using VZV and CMV with and without complement. The neutralizing antibody titers of intact IgG preparations were three to six times higher after addition of complement. The effectiveness of the sulfonated IgG preparation was not enhanced by complement, but desulfonated IgG regained enhanced neutralization activity with complement. Antibody-dependent cellular cytotoxicity (ADCC) toward VZV-infected cells was observed with both intact and sulfonated IVIG and guinea pig splenocytes, but ADCC toward CMV-infected cells was not, although NK cell activity toward cells infected with VZV or CMV was detected by splenocytes. Sulfonated IVIG had no complement-activated neutralization of VZV and CMV but retained ADCC toward VZV with less activity after dilution than with intact IVIG. Because sulfonated IVIG is converted to the intact form after intravenous administration, it would show complement-enhanced neutralization and ADCC activity similar to that of intact IVIG in vivo. In this study we showed the effects of intact and sulfonated IgG on the functional activity of IgG against VZV and CMV.


Subject(s)
Antiviral Agents/immunology , Cytomegalovirus/immunology , Herpesvirus 3, Human/immunology , Immunoglobulin G/immunology , Immunoglobulins, Intravenous/immunology , Animals , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Cell Line , Chickenpox/immunology , Cytomegalovirus Infections/immunology , Guinea Pigs , Humans , Killer Cells, Natural/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...